Content
75%Weight 40%Scale 1-5Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
A highly actionable, well-structured body with executable code, a clear phased workflow, and concrete evidence-grading guidance. The main weakness is redundancy — the Reasoning Strategy and Interpretation Guidance sections duplicate the same caveats, which inflates token cost without adding guidance.
Suggestions
Merge the 'Reasoning Strategy' section with the 'Reasoning Framework for Result Interpretation' section — the direct-vs-indirect distinction, KEGG coverage caveat, and ID-namespace warning each appear twice; state each once.
Add explicit validation checkpoints to the workflow (e.g., 'if KEGG_search_disease returns no entries, retry with disease synonyms or report the disease as not curated in KEGG') to close the minor gaps in the phase sequence.
Consider moving the Evidence Grading table and Interpretation Guidance to a references/ file so SKILL.md stays a lean overview pointing to detail, lifting progressive_disclosure to the top anchor.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | Mostly efficient (tool inventory table, compact code snippets) but noticeably redundant: the 'Reasoning Strategy' paragraph and the later 'Reasoning Framework for Result Interpretation' repeat the same points nearly verbatim — direct-vs-indirect drug-target distinction, 'KEGG coverage is not exhaustive', and the hsa: ID-namespace caveat each appear twice. This fits the 'includes some unnecessary explanation or could be tightened' anchor rather than the 'minor instances' anchor at 4. | 3 / 5 |
Actionability | Fully executable, copy-paste-ready guidance: a complete example workflow with setup (from tooluniverse import ToolUniverse; tu.load_tools()), a 12-tool inventory with key params and realistic IDs (H00031, D09996, hsa:672), and expected output shapes ('result['data'] -> [{"kegg_id": "hsa:672", ...}]'). Specific examples cover the common disease-gene-drug-variant cases. | 5 / 5 |
Workflow Clarity | Clear five-phase sequence (Disease Lookup -> Disease Genes -> Drug Search -> Drug Targets -> Network/Variant Context -> Report) with executable code per phase and a consolidated end-to-end example. 'LOOK UP DON'T GUESS' provides some verification direction, and operations are read-only (no destructive cap applies), but explicit checkpoints like handling empty search results before proceeding are absent — minor validation gaps rather than the missing sequence of anchor 3. | 4 / 5 |
Progressive Disclosure | Good structure with well-labeled sections (Tool Inventory, Workflow, ID Conversion, Integration with Other Skills, Reasoning Framework, Output), one level deep with no nested references, and no bundle files exist so all content lives inline appropriately. Not a 5 because at ~190 lines, content such as the evidence-grading and interpretation-guidance material could be split into reference files to keep SKILL.md a leaner overview. | 4 / 5 |
Total | 16 / 20 Passed |